Needle-Free Injection Market Analysis Overview:
The Needle-Free Injection Market is projected to grow at a significant pace reaching a CAGR of approximately 15 %, over the forecast period of 2022–2030, despite a considerable fall in product sales during the initial phase of pandemic spread and lockdown restrictions imposed globally. The powder-based type segment of the needle-free injections market is expected to significantly grow in the forecast period.
Needle-free injections market are used for vaccines and medicine administration without causing any harm to the layers of skin of patients. Additionally, it boosts mass immunization among the population by eliminating needle injury anxiety which strengthens the growth of the needle-free injection market.
In a recent research report by Market Research Community, the Needle-Free Injection Market is expected to surpass USD 430 Million by the year 2030, from USD 122 Million in 2021.
Top Key Players of the Needle-Free Injection Market:
The report includes a regional analysis and country analysis with the latest trends, along with the major key players including PharmaJet, Medical International Technology, Inc, NuGen Medical Devices, Portal Instruments, PenJet Corporation, Antares Pharma Inc., Crossject, Bioject Medical Technologies.
The powder-based needle-free injection penetrates the layers of skin with precision to complete the therapeutic dosage levels of the medicine. The concentration levels of powder used in the drug formulation supports the effective absorption of solution in patients’ skin.
Type Covered in This Report Are:
Liquid-based
Projectile/depot-based
Powder-based
On the Basis of Application:
Vaccine Delivery,
Insulin Delivery,
Pain Management,
Others
Regional Analysis:
North America– (U.S., Canada, Mexico)
Europe- (Germany, France, U.K., Russia, Italy, Spain, BENELUX, Rest of Europe)
Asia Pacific- (China, Japan, India, South Korea, Australia, ASEAN, Rest of Asia Pacific)
Latin America- (Brazil, Argentina, Chile, Rest of Latin America)
Middle East and Africa- (GCC, Turkey, Israel, Rest of MEA)
Asia Pacific is expected to contribute a larger share to the needle-free injections market in the estimated period. The adoption of technologies and government initiatives are key factors to the growth of the needle-free injections market. Additionally, in China and India, the enhancement of private-sector hospitals and clinics in rural areas and increased investments from major market players are supporting the market growth in the APAC region.
Get Full Report @ https://marketresearchcommunity.com/needle-free-injection-market/
The study is consolidated into major segments such as by Type (liquid-based, projectile/depot-based, and powder-based), By Product (Fillable, Prefilled), By Delivery Site (Subcutaneous, Intramuscular, and Intradermal), By Technology (Jet-Based, Spring Global, Laser-Powered, and Vibration-Based) By Application (Vaccine Delivery, Insulin Delivery, Pain Management, Others), Industry, End-use (Hospitals Clinics, Home Care Settings, Research Laboratories), and by Region (Asia Pacific, Europe, North America, Middle East, and Africa, Latin America) to forecast the market size by value; also includes the analysis of past dynamics from 2016 – 2021, considering 2021 as the base year.
The Research is Answerable to the following key questions:
- Where can business owners locate more potential customers during the forecast period, 2022 - 2030?
- How are the major vendors operating in the Needle-Free Injection Market planning to reach a potential audience in the emerging economies? Why are sales soaring in certain parts, but dismal in other regions of the world?
- How much are the customers willing to pay for the products and services?
- How much is the dimension of the Needle-Free Injection Market catered by the major vendors?
- How often will the customers buy a product or service during the forecast period, 2022 - 2030?
Contact:
